Chatham Capital Group Inc. increased its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 44,476 shares of the company’s stock after purchasing an additional 135 shares […]